Maternal vaccination and risk of hospitalization for Covid-19 in infants

  • 1. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of symptomatic women of childbearing age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22 to October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:16411647.

  • 2. abstain CL, Wallace B., Simeone RM, et al. Risk of stillbirth among women with and without COVID-19 during childbirth hospitalization – United States, March 2020 to September 2021. MMWR Morb Mortal Wkly Rep 2021;70:16401645.

  • 3. AA buttocks, Chemaitelly H, Al-Khal A, et al. Efficacy of SARS-CoV-2 vaccine in preventing confirmed infection in pregnant women. J Clin Invest 2021;131(23):e153662e153662.

  • 4. Dagan N., Barda N., Biron Shental T, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine during pregnancy. NatMed 2021;27:16931695

  • 5. Lipkind HS, Vazquez-Benitez G, De Silva M., et al. Receiving COVID-19 Vaccine During Pregnancy and Prematurity or Small-for-Gestational Age at Birth – Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep 2022;71:2630.

  • 6. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary results of the safety of the Covid-19 mRNA vaccine in pregnant women. N English J med 2021;384:22732282.

  • seven. Zauche LH, Wallace B., Smoots AN, et al. Reception of Covid-19 mRNA vaccines and risk of spontaneous abortion. N English J med 2021;385:15331535.

  • 8. Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Haberg SE. Covid-19 Vaccination during pregnancy and first trimester miscarriage. N English J med 2021;385:20082010.

  • 9. Centers for Control and Prevention of Disasters. COVID-19 vaccines during pregnancy or breastfeeding (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html).

  • ten. Abu Raya B, Edwards KM, Scheifele DW, Halperin S.A.. Whooping cough and influenza vaccination during pregnancy: a review of the landscape. Lancet Infect Dis 2017;17(7):e209e222.

  • 11. Azziz-Baumgartner E, Grohskopf L, Patel M. Realizing the potential of maternal influenza vaccination. JAMA 2021;325:22572259.

  • 12. Omer SB. Maternal immunization. N English J med 2017;376:12561267.

  • 13. Halasa NB, Olson SM, MA state, et al. Effectiveness of Maternal Immunization with COVID-19 mRNA Vaccine During Pregnancy Against COVID-19 Associated Hospitalization in Infants <6 Months of Age - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:264270.

  • 14. Carlsen EE, Magnus MC, Oakley L, et al. Association of COVID-19 vaccination during pregnancy with the incidence of SARS-CoV-2 infection in infants. JAMA Medical Intern 2022 June 1 (Epub ahead of print).

  • 15. Mithal LB, Otero S, Shane ED, Goldstein JA, Miller ES. Cord blood antibodies following maternal vaccination against coronavirus disease 2019 during pregnancy. Am J Obstet Gynecol 2021;225:192194.

  • 16. Beharier O, Plitman Mayo R, Once T., et al. Efficient maternal-to-newborn transfer of SARS-CoV-2 vaccine antibodies and BNT162b2 COVID-19 mRNA. J Clin Invest 2021;131:150319150319.

  • 17. Prabhu M, Murphy E.A., Sukhu AC, et al. Antibody response to messenger RNA vaccination of coronavirus disease 2019 (COVID-19) in pregnant women and transplacental passage in cord blood. Obstet Gynecol 2021;138:278280.

  • 18. pearl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2 specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA 2021;325:20132014.

  • 19. JK Baird, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 antibodies detected in breast milk after vaccination. J Hum Lact 2021;37:492498.

  • 20. Yang YJ |, Murphy E.A., Singh S, et al. Association of gestational age with vaccination against coronavirus disease 2019 (COVID-19), history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and a booster dose of vaccine with maternal and umbilical cord antibody levels at delivery. Obstet Gynecol 2022;139:373380.

  • 21. sidewalk me, Aguero-Rosenfeld ME, Roman AS, JL lighter. High levels of antibodies in the cord blood of pregnant women vaccinated against COVID-19. Am J Obstet Gynecol MFM 2021;3:100481100481.

  • 22. Nir O, Schwartz A., Toussia Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies in parturient women treated with the BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM 2022;4:100492100492.

  • 23. shook LL, Atyeo CG, Yonker LM, et al. Durability of anti-spike antibodies in infants following maternal COVID-19 vaccination or natural infection. JAMA 2022;327:10871089.

  • 24. KJ Brands, Whitaker M, Agathis NT, et al. Hospitalization of infants and children 0-4 years old with laboratory confirmed COVID-19 – COVID-NET, 14 States, March 2020 to February 2022. MMWR Morb Mortal Wkly Rep 2022;71:429436.

  • 25. Hobbs Resume, Woodworth K, Young CC, et al. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Infect Pediatrician Say J 2022;41(3):e81e86.

  • 26. Mølgaard-Nielsen D, Fischer TK, Krause TG, Hvid A. Effectiveness of maternal immunization with inactivated trivalent influenza vaccine in pregnant women and their infants. J Internal Med 2019;286:469480.

  • 27. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of the potentially fatal flu vaccine in American children. Blink Infect Dis 2022 January 13 (Epub ahead of print).

  • 28. acid friends, Feng S, Lewnard JA, et al. The use of test-negative controls to monitor vaccine efficacy: a systematic review of methodology. Epidemiology 2020;31:4364.

  • 29. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of the BNT162b2 vaccine against Critical Covid-19 in adolescents. N English J med 2022;386:713723.

  • 30. Olson SM, Newhams MM, Halasa NB, et al. Efficacy of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization in People Aged 12-18 Years – United States, June-September 2021. MMWR Morb Mortal Wkly Rep 2021;70:14831488.

  • 31. Federal Registry Office. Code of Federal Regulations: a one-time eCFR system. Title 45 (https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&mc=true&node=pt45.1.46&rgn=div5#se45.1.46_1102).

  • 32. Razzaghi H, Megani M, Pingali C, et al. COVID-19 vaccination coverage in pregnant women during pregnancy – eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep 2021;70:895899.

  • 33. Patel MK, Bergeri I, Bresee JS, et al. Evaluation of post-introduction COVID-19 vaccine efficacy: summary of interim guidance from the World Health Organization. Vaccine 2021;39:40134024.

  • 34. Centers for Control and Prevention of Disasters. COVID data tracker: variable proportions (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).

  • 35. KJ gray, Bordt EA, Atyeo C, et al. Vaccine response against coronavirus disease 2019 in pregnant and lactating women: a cohort study. Am J Obstet Gynecol 2021;225(3):303.e1303.e17.

  • 36. PN Klein, Stockwell SP, Demarco M, et al. Efficacy of Pfizer-BioNTech BNT162b2 COVID-19 mRNA Vaccination in Preventing Emergency and Urgent Care Visits and Hospitalizations Associated with COVID-19 in Non-Immunocompromised Children and Adolescents Aged 5-17 Years – VISION Network , 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:352358.

  • 37. Laura AS, Tenford MW, JD Chappell, et al. Clinical severity and efficacy of mRNA vaccines against Covid-19 from omicron, delta and alpha variants of SARS-CoV-2 in the United States: prospective observational study. BMJ 2022;376:e069761e069761.

  • 38. Centers for Control and Prevention of Disasters. Cumulative data on file: Percentage of pregnant women ages 18-49 receiving at least one dose of a COVID-19 vaccine during pregnancy, by race/ethnicity and date of notification to CDC-Vaccine Safety Datalink*, United States | December 20, 2020–January 20, 2022 (https://data.cdc.gov/Vaccinations/Cumulative-Data-Percent-of-Pregnant-People-aged-18/4ht3-nbmd/data).

  • 39. Nemet I, L-clicker, Funny Y, et al. Third neutralization by BNT162b2 vaccination of SARS-CoV-2 omicron infection. N English J med 2022;386:492494.

  • 40. Thompson MG, Natarajan K, Irving SA, et al. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19 Associated Emergency and Urgent Care Visits and Adult Hospitalizations During Periods of Delta and Omicron Variant Prevalence – VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:139145.

  • >

    Leave a Comment